Skip to content

Effect of transcutaneous auricular vagus nerve stimulation on postoperative delirium in elderly patients with hip fracture

Effect of transcutaneous auricular vagus nerve stimulation on postoperative delirium in elderly patients with hip fracture

Status
Active, not recruiting
Phases
Early Phase 1
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2400085508
Enrollment
Unknown
Registered
2024-06-11
Start date
2024-06-15
Completion date
Unknown
Last updated
2024-07-08

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

postoperative delirium

Interventions

Sponsors

Chongqing Traditional Chinese Medicine Hospital
Lead Sponsor

Eligibility

Sex/Gender
All
Age
65 Years to No maximum

Inclusion criteria

Inclusion criteria: ?Age =65 years old; ? Planned elective operation with fragile hip fractures (femoral neck, femoral head, intertrochanteric or subtrochanteric fractures); ?American Society of Anesthesiologists (ASA) physical status I to IV

Exclusion criteria

Exclusion criteria: (1) Patients with chronic fractures, multiple trauma or fractures; (2) People with serious primary or secondary diseases, such as severe diseases of the liver, kidney and hematopoietic system, severe cardiopulmonary insufficiency or infectious diseases; (3) Prior to surgery, there was a clear history of neurological or psychiatric disorders or the use of corresponding medications; (4) A person who is addicted to drugs, alcohol or other substances; (5) Recent use of cholinergic and anticholinergic drugs and hormones; (6) Inflammation and a history of taking anti-inflammatory drugs; (7) Local skin rash, infection, lesions, ulcers, scars in the ear concha region; (8) Bradycardia (heart rate < 60 beats/min); (9) Patients with a history of implantable stimulators (such as pacemakers, implantable vagus nerve stimulators, deep brain stimulators, spinal cord electrical stimulators, etc.), cochlear implants, and metal implants in the body (except stomatology); (10) Communication problems, such as severe hearing or visual impairment; (11) Who refuse to participate or participate in another randomized clinical trial.

Design outcomes

Primary

MeasureTime frame
Incidence of postoperative delirium;

Secondary

MeasureTime frame
Incidence of dNCR;AChE level in peripheral blood;Unplanned ICU admission rate;Length of stay, cost of stay;Incidence of postoperative complications;Postoperative mortality;BChE level in peripheral blood;TNF-a level in peripheral blood;IL-1ß level in peripheral blood;IL-6 level in peripheral blood;S-100ß level in peripheral blood;

Countries

China

Contacts

Public ContactZhang liang

Chongqing Traditional Chinese Medicine Hospital

seamanzl@126.com+86 137 5292 3978

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026